<DOC>
	<DOCNO>NCT02101749</DOCNO>
	<brief_summary>This prospective , Open label randomize study . A total 220 adult age ≥ 60 year enrol randomize one 2 study arm : 1 . Seasonal inactivate intradermal influenza vaccine ( 15 μg HA ( hemagglutinin ) per strain/ 0.1 ml dose ) ( group A - 110 participant ) 2 . Seasonal inactivate intramuscular influenza vaccine ( 15 μg HA per strain/ 0.5 ml dose ) ( group B - 110 participant ) Groups A B receive vaccine day 1 . Total follow period 60 day .</brief_summary>
	<brief_title>Immune Response Intradermal Intramuscular Preparations Inactive Seasonal Influenza Vaccine Older Age Group .</brief_title>
	<detailed_description>The consent form review sign participant prior study-related procedure . Potential study participant assess base inclusion exclusion criterion . Screening procedure , include take medical history , vital sign , random blood dextrostix vaccination perform day 1 . A total 220 participant randomize 2 study arm , group 110 vaccinee receive either seasonal intradermal influenza vaccine [ group A ] seasonal intramuscular influenza vaccine [ group B ] . The randomization route vaccination keep conceal envelope study site . It open subject sign informed consent form inclusion exclusion criterion meet enrollment . Groups A B receive vaccine day 1 . Clinical activity group A B visit ( total 5 visit ) . Blood drawn assay ( baseline assessment ) use HAI ( hemagglutination inhibition assay ) three influenza strain .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Inclusion criterion : Male female age ≥ 60 year Healthy and/or medically stable control chronic medical condition ( e.g . diabetes mellitus , hypertension ) able help oneself Exclusion criterion : Known history systemic hypersensitivity egg chicken proteins vaccine component Influenza infection within past 3 month History Guillain Barre Syndrome ( GBS ) brachial neuritis within 6 week previous influenza vaccination Treatment immunosuppressive immunemodifying drug cancer therapy within past 6 month Any concomitant medication aspirin Participation intervention study Incapacity provide fully inform consent attentive followup observation result cognitive impairment , abuse alcohol drug addiction Random blood Dextrostix 200 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>trivalent inactivate influenza vaccine</keyword>
</DOC>